Center-Authored Papers

Filters: Author is Kwon, Erika M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Fitzgerald LM, Agalliu I, Johnson K, Miller MA, Kwon EM, Hurtado-Coll A, Fazli L, Rajput AB, Gleave ME, Cox ME et al..  2008.  Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer.. BMC cancer. 8:230. Abstract
Holt SK, Karyadi DM, Kwon EM, Stanford JL, Nelson PS, Ostrander EA.  2008.  Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(12):3823-31. Abstract
Johanneson B, McDonnell SK, Karyadi DM, Hebbring SJ, Wang L, Deutsch K, McIntosh L, Kwon EM, Suuriniemi M, Stanford JL et al..  2008.  Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb.. Human genetics. 123(1):65-75. Abstract
2009
Holt SK, Kwon EM, Peters U, Ostrander EA, Stanford JL.  2009.  Vitamin D pathway gene variants and prostate cancer risk.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(6):1929-33. Abstract
Fitzgerald LM, Kwon EM, Koopmeiners JS, Salinas CA, Stanford JL, Ostrander EA.  2009.  Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(9):3231-7. Abstract
Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA et al..  2009.  Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.. Nature genetics. 41(10):1116-21. Abstract
Zhu Y, Stevens RG, Hoffman AE, Fitzgerald LM, Kwon EM, Ostrander EA, Davis S, Zheng T, Stanford JL.  2009.  Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study.. Cancer research. 69(24):9315-22. Abstract
Salinas CA, Koopmeiners JS, Kwon EM, FitzGerald L, Lin DW, Ostrander EA, Feng Z, Stanford JL.  2009.  Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.. The Prostate. 69(4):363-72. Abstract
2010
Wright JL, Kwon EM, Lin DW, Kolb S, Koopmeiners JS, Feng Z, Ostrander EA, Stanford JL.  2010.  CYP17 polymorphisms and prostate cancer outcomes.. The Prostate. 70(10):1094-101. Abstract
Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL.  2010.  Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study.. Cancer causes & control : CCC. 21(2):289-300. Abstract
Holt SK, Kwon EM, Lin DW, Ostrander EA, Stanford JL.  2010.  Association of hepsin gene variants with prostate cancer risk and prognosis.. The Prostate. 70(9):1012-9. Abstract
Salinas CA, Kwon EM, Fitzgerald LM, Feng Z, Nelson PS, Ostrander EA, Peters U, Stanford JL.  2010.  Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk.. American journal of epidemiology. 172(5):578-90. Abstract
Holt SK, Kwon EM, Koopmeiners JS, Lin DW, Feng Z, Ostrander EA, Peters U, Stanford JL.  2010.  Vitamin D pathway gene variants and prostate cancer prognosis.. The Prostate. 70(13):1448-60. Abstract
Udler MS, Ahmed S, Healey CS, Meyer K, Struewing J, Maranian M, Kwon EM, Zhang J, Tyrer J, Karlins E et al..  2010.  Fine scale mapping of the breast cancer 16q12 locus.. Human molecular genetics. 19(12):2507-15. Abstract
Langeberg WJ, Tahir SA, Feng Z, Kwon EM, Ostrander EA, Thompson TC, Stanford JL.  2010.  Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes.. The Prostate. 70(9):1020-35. Abstract
Langeberg WJ, Kwon EM, Koopmeiners JS, Ostrander EA, Stanford JL.  2010.  Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(1):258-64. Abstract
2011
Wright JL, Kwon EM, Ostrander EA, Montgomery BR, Lin DW, Vessella R, Stanford JL, Mostaghel EA.  2011.  Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(4):619-27. Abstract
Kwon EM, Salinas CA, Kolb S, Fu R, Feng Z, Stanford JL, Ostrander EA.  2011.  Genetic polymorphisms in inflammation pathway genes and prostate cancer risk.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(5):923-33. Abstract
Lin DW, Fitzgerald LM, Fu R, Kwon EM, Zheng SL, Kolb S, Wiklund F, Stattin Pär, Isaacs WB, Xu J et al..  2011.  Genetic Variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(9):1928-36. Abstract
Wright JL, Neuhouser ML, Lin DW, Kwon EM, Feng Z, Ostrander EA, Stanford JL.  2011.  AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk.. The Prostate. 71(5):498-506. Abstract
Fitzgerald LM, Kwon EM, Conomos MP, Kolb S, Holt SK, Levine D, Feng Z, Ostrander EA, Stanford JL.  2011.  Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(6):1196-203. Abstract
Kote-Jarai Z, Al Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Campa D, Riboli E, Key T, Gronberg H et al..  2011.  Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.. Nature genetics. 43(8):785-791. Abstract
2012
Kwon EM, Holt SK, Fu R, Kolb S, Williams G, Stanford JL, Ostrander EA.  2012.  Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk.. Cancer epidemiology. Abstract
Fitzgerald LM, Zhang X, Kolb S, Kwon EM, Liew YC, Hurtado-Coll A, Knudsen BS, Ostrander EA, Stanford JL.  2012.  Investigation of the Relationship Between Prostate Cancer and MSMB and NCOA4 Genetic Variants and Protein Expression.. Human mutation. Abstract
2013
Al Olama AA, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC et al..  2013.  A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.. Human molecular genetics. 22(2):408-15. Abstract